Website Preloader

Cell and gene
therapy

"
"
Providing the optimum environment to maximize access to cell and gene therapies globally
Providing the optimum environment to maximize access to cell and gene therapies globally

Innovative therapy access

Uniphar is the global leading expert in cell and gene therapy access, guiding groundbreaking therapies to support commercialization.

Our expanded access experience has shown how these programs are integral to a successful strategy for cell and gene therapy.

Our pillars of service

With extensive expertise across the full product lifecycle, we navigate complex scientific, regulatory and operational challenges to deliver tailored solutions that optimize patient access worldwide.

CGT platform
Our proprietary CGT platform allows us to streamline and optimize strategy from early access to commercialization and sustained market success
Experience

Our unrivalled experience spanning multiple cell and gene therapy access programs, combined with an expert team ensure confidence and success in facilitating patient access world wide

Regulatory navigation
We expertly navigate complex, global regulatory landscapes, ensuring compliant and appropriate pathways that accelerate patient access to lifechanging cell and gene therapies
Execution excellence
Our processes and methodologies have been shaped by extensive
experience to ensure meticulous execution of complex initiatives. Our global platform draws together multifunctional teams and infrastructure for execution excellence
Strategic partnerships
Uniphar’s global team are experts in establishing and maintaining long-term strategic partnerships. We work with you to create, develop and implement the most appropriate strategic plan for your asset
Innovation
We know that groundbreaking treatments can require novel strategies and ways of working that redefine the boundaries. We pride ourselves on our agility and continual evolution to meet emerging challenges
Cell and gene global expertise
0

50 countries served

1yrs

6 years’ CGT experience

0+

500+ patients treated

From our partners

Expert insights
Equitable access: How can we make cell and gene therapies a reality or possibility for all mankind?

Equitable access: How can we make cell and gene therapies a reality or possibility for all mankind?

The role of expanded access in cell and gene therapy

The role of expanded access in cell and gene therapy

Cross-border Expanded Access Programs: Reducing barriers to treatment access

Cross-border Expanded Access Programs: Reducing barriers to treatment access

Three key steps to bring EAPs to a global market

Three key steps to bring EAPs to a global market

Learn more about our service areas

Enabling equitable access

$
Tailored medical
affairs
$

Commercial services for pharma

$

Your CGT partner

Whether it’s an expanded access program, regulatory approval, reimbursement strategy or commercial launch, we have the agility and vision to stay ahead of the curve in this rapidly evolving landscape.

Trust us to be your partner, unlocking the transformative potential of cell and gene therapies for patients globally.